Sharps Technology, Inc. (STSS)
USD 4.75
(-9.35%)
USD 4.75
(-9.35%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 3.85 Million USD | 75.34% |
| 2022 | 2.19 Million USD | -20.52% |
| 2021 | 2.76 Million USD | 2632.14% |
| 2020 | 101.24 Thousand USD | 0.76% |
| 2019 | 100.48 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 2.94 Million USD | -23.65% |
| 2024 Q2 | 2.71 Million USD | -7.75% |
| 2023 Q4 | 3.85 Million USD | 2.09% |
| 2023 Q2 | 3.1 Million USD | 21.08% |
| 2023 FY | 3.85 Million USD | 75.34% |
| 2023 Q1 | 2.56 Million USD | 16.64% |
| 2023 Q3 | 3.77 Million USD | 21.62% |
| 2022 Q3 | 3.81 Million USD | 26.1% |
| 2022 FY | 2.19 Million USD | -20.52% |
| 2022 Q2 | 3.02 Million USD | -8.58% |
| 2022 Q1 | 3.3 Million USD | 19.58% |
| 2022 Q4 | 2.19 Million USD | -42.35% |
| 2021 Q1 | - USD | -100.0% |
| 2021 Q3 | 321.99 Thousand USD | 175.81% |
| 2021 Q4 | 2.76 Million USD | 759.07% |
| 2021 FY | 2.76 Million USD | 2632.14% |
| 2021 Q2 | 116.74 Thousand USD | 0.0% |
| 2020 Q4 | 101.24 Thousand USD | 0.0% |
| 2020 FY | 101.24 Thousand USD | 0.76% |
| 2019 FY | 100.48 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 126.59 Million USD | 96.955% |
| AngioDynamics, Inc. | 112.08 Million USD | 96.561% |
| AtriCure, Inc. | 147.76 Million USD | 97.391% |
| Avinger, Inc. | 19.97 Million USD | 80.698% |
| Azenta, Inc. | 351.22 Million USD | 98.902% |
| BioLife Solutions, Inc. | 75.05 Million USD | 94.864% |
| The Cooper Companies, Inc. | 4.1 Billion USD | 99.906% |
| Daxor Corporation | 858.75 Thousand USD | -348.902% |
| Ekso Bionics Holdings, Inc. | 16.31 Million USD | 76.367% |
| Femasys Inc. | 9.4 Million USD | 59.004% |
| GlucoTrack, Inc. | 1.7 Million USD | -125.702% |
| Harvard Bioscience, Inc. | 64.29 Million USD | 94.004% |
| Hologic, Inc. | 4.02 Billion USD | 99.904% |
| ICU Medical, Inc. | 2.25 Billion USD | 99.829% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | 99.811% |
| KORU Medical Systems, Inc. | 8.1 Million USD | 52.45% |
| LeMaitre Vascular, Inc. | 48.87 Million USD | 92.113% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -484.145% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -484.145% |
| Masimo Corporation | 1.67 Billion USD | 99.77% |
| Microbot Medical Inc. | 3.82 Million USD | -0.758% |
| Meihua International Medical Technologies Co., Ltd. | 25.07 Million USD | 84.628% |
| Merit Medical Systems, Inc. | 1.12 Billion USD | 99.657% |
| Nephros, Inc. | 3.5 Million USD | -10.048% |
| NovoCure Limited | 783.63 Million USD | 99.508% |
| NEXGEL, Inc. | 4.78 Million USD | 19.503% |
| NEXGEL, Inc. | 4.78 Million USD | 19.503% |
| Singular Genomics Systems, Inc. | 86.46 Million USD | 95.541% |
| OraSure Technologies, Inc. | 52.17 Million USD | 92.611% |
| Pro-Dex, Inc. | 23.34 Million USD | 83.485% |
| Pulse Biosciences, Inc. | 16.44 Million USD | 76.557% |
| Predictive Oncology Inc. | 6.14 Million USD | 37.271% |
| Precision Optics Corporation, Inc. | 6.84 Million USD | 43.68% |
| QuidelOrtho Corporation | 3.55 Billion USD | 99.892% |
| Repligen Corporation | 853.2 Million USD | 99.548% |
| Sanara MedTech Inc. | 29.28 Million USD | 86.835% |
| STAAR Surgical Company | 102.73 Million USD | 96.248% |
| Utah Medical Products, Inc. | 7.14 Million USD | 46.046% |
| DENTSPLY SIRONA Inc. | 4.07 Billion USD | 99.905% |
| Jin Medical International Ltd. | 8.92 Million USD | 56.804% |